To assess the biological characteristics of transitional-cell carcinoma of
the bladder (TCC), Stage T-1, which may be helpful in evaluating the approp
riate treatment at this stage of disease, urine from 78 newly presenting pa
tients who were candidates for transurethral resection (TUR) of tumors was
analyzed cytologically and the number of tumors in each patient counted. In
addition, the following biological characteristics of the resected tumors
were examined: grade, cellular atypia, nuclear area, mitotic index, diploid
fraction, S-phase fraction (percent), DNA index, and aneuploid fraction (n
umber). The biological features were compared with the clinical status of p
atients. In 46 patients, the tumors were Stage pT(a) Grade 1-3; 19 were Sta
ge pT(1) Grade 2-3, and 13 were Stage pT(2,3). The T-1 category of TCC appe
ared far more aggressive than T-a TCC after examining the various biologica
l features, and when considering mitotic index and urine cytology, it was f
ound to be more aggressive even in comparison with the T-2,T-3 category. Th
e maximum mitotic index in the T-2,T-3 category was 19.2; in the T-1 catego
ry, 53% of the tumors had a higher mitotic index. The minimal mitotic index
found in the T-1 category in our study was 4.07. There was no correlation
between the number of tumors and the stage of the disease. Among the 15 pat
ients at stage T-1 who were available for follow-up, in 8 patients, a mitot
ic index above 19.2 was found, and they were considered at high risk for pr
ogression. In this subgroup of patients, the time to first recurrence was s
ignificantly shorter than in the subgroup of T1 patients with a mitotic ind
ex below 19.2 (6.13 +/- 1.3 v 11.5 +/- 1.93 months). In the high-risk subgr
oup, two patients died of metastatic disease, whereas only one patient from
the low-risk subgroup died, and that was of causes not related to carcinom
a of the bladder. Biologically, TCC at Stage T-1 is far more aggressive tha
n T-a TCC and cannot be classified as a superficial tumor. Tumors at Stage
pT(1) with a mitotic index above 19.2 constitute a very malignant subgroup
of T-1 tumors and may appropriately be treated by radical cystectomy after
the first recurrence.